Clinical work-up for neurofibromatosis type 1 (NF1);Bilan dans la neurofibromatose de type 1

Presse Medicale

Volumn 28, Issue 39, 1999, Pages 2174-2180

  Wolkenstein, P ^a   Zeller, J ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAFE AU LAIT SPOT; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HAMARTOMA; HUMAN; HYPERTENSION; LENTIGO; NEUROFIBROMATOSIS; PSEUDARTHROSIS; REVIEW; SCOLIOSIS;

HUMANS; NEUROFIBROMATOSIS 1;

EID: 0033547573     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. The neurofibromatoses: a pathogenetic and clinical overview. Huson SM, Hughes RAC eds. Chapmann and Hall, London, 1994.
2. Neurofibromatosis: Phenotype, natural history, and pathogenesis. Riccardi VM., Johns Hopkins University Press, Baltimore, 1992.
3. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981 ; 305:1617-27.
4. Neurofibromatoses: a handbook for patients, families, and health-care professionals. Rubenstein AE, Korf BR. Thieme Medical Publishers, Inc, New York, 1990
5. Ledbetter DH, Rich DC, O'Connell P, Leppert M, Carey JC Precise localization of NF1 to 17q11.2 by balanced translation. Am J Hum Genet 1989; 44:20-4.
6. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 13:2-17.
7. Bahuau M, Vidaud M, Vidaud D. Revue : Neurofibromatose. Génétique et physiopathologie moléculaire de là NF1. M/T 1997 ; 3:623-8.
8. Gutmann DH, Collins FS. Neurofibromatosis type 1. Beyond positional cloning. Arch Neurol 1993; 50 : 1185-93.
9. Huson SM, Compston DAS, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. II: Guidelines for genetic counselling. J Med Genet 1989; 26:712-21.
10. NIH Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol 1988; 45:575-8.
11. Zeller J, Hovnanian A. La maladie de von Recklinghausen. Ann Dermatol Venereol 1992 ; 119:405-10.
12. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 1995 ; 127:718-22.
13. Listemick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with reurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997 ; 41:143-9.
14. Friedman JM, Birch PH. Type 1 neurofibromatosis - a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997 ; 70:138-43.
15. Samuelsson B, Axelsson R. Neurofibromatosis: A clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Dermato-venereologica 1981 ; S95:67-71
16. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986; 314: 1010-5.
17. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteberg, Sweden. Acta Derm Venereol 1995 ; 75:136-40.
18. Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neur Sci 1996 ; 138:125-33.
19. Nguyen The Tich S, Mahé J-Y, Coutant X, Gloanec Y, Pedvrel E. Revue : Neurofibromatose. Troubles de l'apprentissage: dépistage et prise en charge. M/T 1997; 3: 636-9.
20. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuda J-I. Neurofibromatosis type 1 and childhood cancer. Cancer 1993; 72 : 2746-54.
21. Eichenfield LF, Levy ML, Paller AS et al. Guidelines of care for neurofibromatosis type 1. J Am Acad Dermatol 1997 ; 37:625-30.
22. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997 ; 278:51-7.
23. Wolkenstein P, Frèche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1: a study of 152 patients. Arch Dermatol 1996 ; 132: 1333-6
24. Huson SM. What level of care for the neurofibromatoses? Lancet 1999 ; 353:1114-5